acamprosate vs valbenazine
Side-by-side comparison of acamprosate and valbenazine Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Campral
Ingrezza
Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking. It should be used with counseling and support.
Ingrezza and Ingrezza Sprinkle are medicines used to treat movement problems. They can help with tardive dyskinesia and chorea caused by Huntington's disease.
Acamprosate helps people who are alcohol-dependent to not drink alcohol. You must have already stopped drinking before you start taking acamprosate. This medicine works best when it is part of a complete treatment plan that includes counseling and support.
This medicine treats tardive dyskinesia in adults. Tardive dyskinesia causes repetitive, uncontrolled movements. It also treats chorea, which is involuntary, jerky movements, in adults with Huntington's disease.
Acamprosate is similar to a natural substance in your brain. It is thought to work by helping to restore the normal balance of brain activity that is changed by long-term alcohol use. This can reduce your craving for alcohol.
Ingrezza works by affecting a protein in your brain called VMAT2. This protein helps control the release of certain chemicals. By blocking VMAT2, Ingrezza helps reduce unwanted movements.
- • Accidental injury
- • Weakness
- • Pain
- • Loss of appetite
- • Diarrhea
- • Sleepiness
- • Lethargy
- • Sedation
- • Urticaria (hives)
- • Rash
- Low blood pressure 14
- Weakness 13
- Condition worsened 13
- Using the medicine for something it is not approved for 13
- Sudden kidney damage 12
- The medicine is not working 2,719
- Sleepiness 2,412
- Tiredness 1,646
- Shaking 1,539
- Uncontrolled movements 1,471
Acamprosate may increase the risk of suicidal thoughts or actions. Your doctor should watch you for depression or suicidal thoughts. Tell your doctor right away if you have any new or worsening symptoms of depression or suicidal thoughts.
Ingrezza can increase the risk of depression and suicidal thoughts in people with Huntington's disease. Your doctor will monitor you closely for any changes in mood or behavior. Tell your doctor right away if you have any thoughts of harming yourself.
Acamprosate may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acamprosate passes into breast milk. Talk to your doctor if you are breastfeeding.
Ingrezza may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. You should not breastfeed while taking Ingrezza.
Also Compare — Nearby Drugs
Compare valbenazine with
How to Read This acamprosate vs valbenazine Comparison
acamprosate is classified in the GABA Analog (Alcohol Dependence) drug class, while valbenazine sits within the VMAT2 Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acamprosate has 65 submissions while valbenazine has 9,787. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acamprosate and valbenazine — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.